Reach Us
Niir Project Consultancy Services (NPCS)
AN ISO 9001 : 2015 CERTIFIED COMPANY
106-E, Kamla Nagar,Opposite Spark Mall,
New Delhi-110007, India.
Email: npcs.ei@gmail.com,
info@entrepreneurindia.co
Tel: 91-11-23843955, 23845654, 23845886, +91-8800733955
Mobile: +91-9811043595
Fax: 91-11-23845886
Web: www.entrepreneurindia.co
  • Join Us On
Reach Us
Quick Enquiry
 
   
   
Quick Enquiry
Add to wishlist Add to cart Add to inquiry Buy now Download page as pdf

Global Conjugate Vaccine Market (2018-2023) ( ) ( )

Author Netscribes ISBN -
Code ENI416 Format CD-Rom
Price: Rs 299925   299925 + Tax @ 18.00 % US$ 3999   3999
Pages: 100 Published 2018
Publisher Netscribes  
Usually Ships within 5

"Global Conjugate Vaccine Market:


Conjugate vaccine is a type of vaccine that contains bacterial capsular polysaccharide, attached to a protein to enhance immunogenicity and protect against invasive diseases. The global conjugate vaccine market is expected to grow at a CAGR of 14.6%, leading to a global revenue of USD 100.59 Bn by 2023. By volume, it is anticipated to reach 9600.56 Million units by 2023, expanding at a CAGR of 17.2%.


The conjugate vaccine market is classified into two primary segments-based on disease indication: pneumococcal, haemophilus influenza type b, diphtheria-tetanus-pertussis, meningococcal and others; and based on end user: paediatric and adult. Asia-Pacific will have the highest CAGR during the forecasted period. 


Key growth factors:


o Rising adoption of cancer therapeutic vaccines, improvement in patient compliance along with an increasing product pipeline, and growing efforts for the adoption of appropriate preventive screening methods to help avert adverse reactions will accelerate the market. 

o Conjugate Vaccine market is expected to have positive growth owing to technological advancements, growth initiatives for the production of low-cost vaccines, and widespread routine vaccination programs in emerging economies.


Threats and key players:

o Although the conjugate vaccine market is expected to have a positive growth globally, lack of awareness, shortage risk, the situation of oligopoly, uncertainty about the future of international initiatives, emerging manufacturers, and costs and prices of new vaccines will hinder growth.

o Major Conjugate Vaccine providers operating in the market are GlaxoSmithKline, Pfizer Inc., Sanofi Pasteur, Novartis, etc. 


What’s covered in the report?


1. Overview of the global conjugate vaccine market

2. Market drivers and challenges in the global conjugate vaccine market

3. Market trends in the global conjugate vaccine market

4. Historical, current and forecasted market size data for the global disease indication segment (pneumococcal, haemophilus influenza type b, diphtheria-tetanus-pertussis, meningococcal conjugate vaccines) – by revenue and by volume

5. Historical, current and forecasted market size data for the global end user segment (paediatric and adult conjugate vaccines) – by revenue and by volume

6. Historical, current and forecasted regional (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) market size data for the conjugate vaccine market – by revenue and by volume

7. Historical, current and forecasted market size data for the region-wise conjugate vaccine market segments – by revenue and by volume

8. Analysis of the competitive landscape and profiles of major companies operating in the market


Why buy?


o Understand the demand for conjugate vaccines to determine the viability of the market

o Determine the developed and emerging markets where conjugate vaccines are provided

o Identify the challenge areas and address them

o Develop strategies based on the drivers, trends and highlights for each of the segments

o Evaluate the value chain to determine the workflow  and to get an idea of the current position where you are placed

o Recognize the key competitors of this market and respond accordingly

o Knowledge of the initiatives and growth strategies  taken up by the major companies and decide on the direction for further growth

o Define the competitive positioning by comparing the products and services with the key players in the market


Customizations available

With the given market data, Netscribes offers customizations according to specific needs. Write to us at support@researchonglobalmarkets.com."

 

Chapter 1: Executive summary
 1.1 Market scope and segmentation
 1.2 Key questions answered in this study
 1.3 Executive summary - I
 1.4 Executive summary – II

Chapter 2: Market overview
2.1. Market definitions
2.2. Global market overview – by revenue
               - Global historical (2015-2017) market revenue (USD Bn)
               - Global forecasted (2018-2023) market revenue (USD Bn)
               - Geography-wise market (2018-2023) revenue (USD Bn)
2.3. Global market overview – by volume
               - Global historical (2015-2017) market volume (Million units)
               - Global forecasted (2018-2023) market volume (Million units)
               - Geography-wise (2018-2023) market volume (Million units)
2.4. Global market drivers and challenges
2.4.1. Global market drivers
2.4.2. Global market challenges
2.5. Global market trends
2.6. Value chain
2.7.1. Regional market overview - North America
- Observation
- Key competitors
2.7.1(A) Regional market overview – North America by revenue and by volume
- North America historical (2015-2017) market revenue (USD Bn)
- North America forecasted (2018-2023) market revenue (USD Bn)
- North America historical (2015-2017) market volume (Million units)
- North America forecasted (2018-2023) market volume (Million units)
2.7.2. Regional market overview – Europe
- Observation
- Key competitors
2.7.2(A) Regional market overview – Europe by revenue and by volume
- Europe historical (2015-2017) market revenue (USD Bn)
- Europe forecasted (2018-2023) market revenue (USD Bn)
- Europe historical (2015-2017) market volume (Million units)
- Europe forecasted (2018-2023) market volume (Million units)
2.7.3. Regional market overview – Asia-Pacific
- Observation
- Key competitors
2.7.3(A) Regional market overview – Asia Pacific by revenue and by volume
- Asia Pacific historical (2015-2017) market revenue (USD Bn)
- Asia Pacific forecasted (2018-2023) market revenue (USD Bn)
- Asia Pacific historical (2015-2017) market volume (Million units)
- Asia Pacific forecasted (2018-2023) market volume (Million units)
2.7.4. Regional market overview – Latin America
- Observation
- Key competitors
2.7.4(A) Regional Market Overview – Latin America by revenue and by volume
- Latin America historical (2015-2017) market revenue (USD Bn)
- Latin America forecasted (2018-2023) market revenue (USD Bn)
- Latin America historical (2015-2017) market volume (Million units)
- Latin America forecasted (2018-2023) market volume (Million units)
2.7.5. Regional market overview – Middle East & Africa
- Observation
- Key competitors
2.7.5(A) Regional market overview – Middle East & Africa by revenue and by volume
- Middle East & Africa historical (2015-2017) market revenue (USD Bn)
- Middle East & Africa forecasted (2018-2023) market revenue (USD Bn)
- Middle East & Africa historical (2015-2017) market volume (Million units)
- Middle East & Africa forecasted (2018-2023) market volume (Million units)

Chapter 3: Major segment overview - global by disease indication
3.1. Disease indication: Pneumococcal, Hib - by revenue, by volume, CAGR
- Overview - by disease indication
- Market share (2015, 2018 & 2023): Pneumococcal – global revenue (USD Bn)
- Market share (2015, 2018 & 2023): Pneumococcal – global volume (Million units)
- Market share (2015, 2018 & 2023): Hib – global revenue (USD Bn)
- Market share (2015, 2018 & 2023): Hib – global volume (Million units)
3.2. Disease indication: DTP, Meningococcal - by revenue, by volume, CAGR
- Overview - by disease indication
- Market share (2015, 2018 & 2023): DTP – global revenue (USD Bn)
- Market share (2015, 2018 & 2023): DTP – global volume (Million units)
- Market share (2015, 2018 & 2023): Meningococcal – global revenue (USD Bn)
- Market share (2015, 2018 & 2023): Meningococcal – global volume (Million units)

Chapter 4: Major segment overview - global by end user
 4.1. End-user: Pediatric, Adult - by revenue, by volume, CAGR
 - Overview - by end user
- Market share (2015, 2018 & 2023): Paediatric – global revenue (USD Bn)
- Market share (2015, 2018 & 2023): Paediatric – global volume (Million units)
- Market share (2015, 2018 & 2023): Adult – global revenue (USD Bn)
- Market share (2015, 2018 & 2023): Adult – global volume (Million units)

Chapter 5: North America – by disease indication
5.1. North America: disease indication - Pneumococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
5.2. North America: disease indication - Haemophilus Influenza type b conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
5.3. North America: disease indication - Diphtheria-Tetanus-Pertussis conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
5.4. North America: disease indication - Meningococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways

Chapter 6: North America – by end user
6.1. North America: end user - Pediatric & Adult conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Key takeaways

Chapter 7: Europe – by disease indication
7.1. Europe: disease indication - Pneumococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
7.2. Europe: disease indication – Haemophilus Influenza type b conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
7.3. Europe: disease indication - Diphtheria-Tetanus-Pertussis conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
7.4. Europe: disease indication - Meningococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways

Chapter 8: Europe – by end user
8.1. Europe: end user - Pediatric & Adult conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Key takeaways
 
Chapter 9: Asia Pacific – by disease indication
9.1. Asia Pacific: disease indication - Pneumococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
9.2. Asia Pacific: disease indication – Haemophilus Influenza type b conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
9.3. Asia Pacific: disease indication - Diphtheria-Tetanus-Pertussis conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
9.4. Asia Pacific: disease indication - Meningococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways

Chapter 10: Asia Pacific – by end user
10.1. Asia Pacific: end user - Pediatric & Adult conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Key takeaways

Chapter 11: Latin America - by disease indication
11.1. Latin America: disease indication - Pneumococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
11.2. Latin America: disease indication – Haemophilus Influenza type b conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
11.3. Latin America: disease indication - Diphtheria-Tetanus-Pertussis conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
11.4. Latin America: disease indication - Meningococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways

Chapter 12: Latin America - by end user
12.1. Latin America: end user - Pediatric & Adult conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Key takeaways

Chapter 13: Middle East & Africa - by disease indication
13.1. Middle East & Africa: disease indication - Pneumococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
13.2. Middle East & Africa: disease indication – Haemophilus Influenza type b conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
13.3. Middle East & Africa: disease indication - Diphtheria-Tetanus-Pertussis conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
13.4. Middle East & Africa: disease indication - Meningococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways

Chapter 14: Middle East & Africa - by end user
14.1. Middle East & Africa: end user - Pediatric & Adult conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways

Chapter 15: Competitive landscape
15.1. Company market share
- Top 5 companies
15.2. Company overview - GlaxoSmithKline
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
15.2(A) Executive profile – GlaxoSmithKline
15.3. Company overview – Pfizer Inc.
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
15.3(A) Executive profile - Pfizer Inc.
15.4. Company overview – Merck & Co.
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
15.4(A) Executive profile - Merck & Co.
15.5. Company overview – Novartis
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
15.5(A) Executive profile - Novartis
15.6. Company overview – Sanofi Pasteur
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
15.6(A) Executive profile - Sanofi Pasteur
15.7. Company overview – CSL Limited
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
15.7(A) Executive profile - CSL Limited
15.8. Company overview – Bharat Biotech International
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
15.8(A) Executive profile - Bharat Biotech International
15.9. Company overview – Biological E Limited
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
15.9(A) Executive profile - Biological E Limited
15.10. Company overview – Serum Institute of India
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
15.10(A) Executive profile - Serum Institute of India

Appendix
- List of tables
- Assumptions
- Conclusion
-  Research and methodology
-  About Netscribes Inc.

LIST OF FIGURES/ CHARTS
Chapter 2:
1. Global historical (2015-2017) market revenue (USD Bn)
2. Global forecasted (2018-2023) market revenue (USD Bn)
3. Geography-wise (2018-2023) market revenue (USD Bn)
4. Global historical (2015-2017) market volume (Million units)
5. Global forecasted (2018-2023) market volume (Million units)
6. Geography-wise (2018-2023) market volume (Million units)
7. North America historical (2015-2017) market revenue (USD Bn)
8. North America forecasted (2018-2023) market revenue (USD Bn)
9. North America historical (2015-2017) market volume (Million units)
10. North America forecasted (2018-2023) market volume (Million units)
11. Europe historical (2015-2017) market revenue (USD Bn)
12. Europe forecasted (2018-2023) market revenue (USD Bn)
13. Europe historical (2015-2017) market volume (Million units)
14. Europe forecasted (2018-2023) market volume (Million units)
15. APAC historical (2015-2017) market revenue (USD Bn)
16. APAC forecasted (2018-2023) market revenue (USD Bn)
17. APAC historical (2015-2017) market volume (Million units)
18. APAC forecasted (2018-2023)  market volume (Million units)
19. LATAM historical (2015-2017) market revenue (USD Bn)
20. LATAM forecasted (2018-2023) market revenue (USD Bn)
21. LATAM historical (2015-2017) market volume (Million units)
22. LATAM  forecasted (2018-2023) market volume (Million units)
23. MEA historical (2015-2017) market revenue (USD Bn)
24. MEA forecasted (2018-2023) market revenue (USD Bn)
25. MEA historical (2015-2017) market volume (Million units)
26. MEA forecasted (2018-2023) market volume (Million units)
27. Value chain

Chapter 3:
1. Pneumococcal – (2015, 2018, 2023) global revenue(USD Bn)
2. Pneumococcal – (2015, 2018, 2023) global volume (Million units)
3. Hib – (2015, 2018, 2023) global revenue(USD Bn)
4. Hib – (2015, 2018, 2023) global volume (Million units)
5. DTP – (2015, 2018, 2023) global revenue(USD Bn)
6. DTP – (2015, 2018, 2023) global volume (Million units)
7. Meningococcal – (2015, 2018, 2023) global revenue(USD Bn)
8. Meningococcal – (2015, 2018, 2023) global volume (Million units)

Chapter 4:
1. Paediatric – (2015, 2018, 2023) global revenue(USD Bn)
2. Paediatric – (2015, 2018, 2023) global volume(Million units)
3. Adult – (2015, 2018, 2023) global revenue(USD Bn)
4. Adult – (2015, 2018, 2023) global revenue(Million units)

Chapter 5, 7, 9, 11, 13:
1. Pneumococcal conjugate vaccine market –(2015, 2018, 2023) by revenue (USD Bn)
2. Pneumococcal conjugate vaccine market –(2015, 2018, 2023) by volume (Million units)
3. Haemophilus Influenza Type b conjugate vaccine market -(2015, 2018, 2023) by revenue (USD Bn)
4. Haemophilus Influenza Type b conjugate vaccine market -(2015, 2018, 2023) by volume (Million units)
5. Diphtheria-Tetanus-Pertussis conjugate vaccine market -(2015, 2018, 2023) by revenue (USD Bn)
6. Diphtheria-Tetanus-Pertussis conjugate vaccine market -(2015, 2018, 2023) by volume (Million units)
7. Meningococcal conjugate vaccine market -(2015, 2018, 2023) by revenue (USD Bn)
8. Meningococcal conjugate vaccine market -(2015, 2018, 2023) by volume (Million units)

Chapter 6, 8, 10, 12, 14:
1. Pediatric vaccine market -(2015, 2018, 2023) by revenue (USD Bn)
2. Pediatric vaccine market -(2015, 2018, 2023) by volume (Million units)
3. Adult vaccine market -(2015, 2018, 2023) by revenue (USD Bn)
4. Adult vaccine market -(2015, 2018, 2023) by volume (Million units)

Chapter 15:
1. Top 5 companies

LIST OF TABLES
Table 1: Global segment by disease indication (2015 – 2023) value in USD Bn
Table 2: Global segment by disease indication (2015 – 2023) volume in Million units
Table 3: Global segment by end user (2015 – 2023) value in USD Bn
Table 4: Global segment by end user (2015 – 2023) value in Million units
Table 5: Segment by geography (2015 – 2023) value in USD Bn
Table 6: Segment by geography (2015 – 2023) volume in Million units
Table 7: North America - segment by disease indication (2015 – 2023) value in USD Bn
Table 8: North America - segment by end user (2015 – 2023) value in USD Bn
Table 9: North America - segment by disease indication (2015 – 2023) volume in Million units
Table 10: North America - segment by end user (2015 – 2023) volume in Million units
Table 11: Europe - segment by disease indication (2015 – 2023) value in USD Bn
Table 12: Europe - segment by end user (2015 – 2023) value in USD Bn
Table 13: Europe - segment by disease indication (2015 – 2023) volume in Million units
Table 14: Europe - segment by end user (2015 – 2023) volume in Million units
Table 15: APAC - segment by disease indication (2015 – 2023) value in USD Bn
Table 16: APAC - segment by end user (2015 – 2023) value in USD Bn
Table 17: APAC - segment by disease indication (2015 – 2023) volume in Million units
Table 18: APAC - segment by end user (2015 – 2023) volume in Million units
Table 19: LATAM - segment by disease indication (2015 – 2023) value in USD Bn
Table 20: LATAM - segment by end user (2015 – 2023) value in USD Bn
Table 21: LATAM - segment by disease indication (2015 – 2023) volume in Million units
Table 22: LATAM - segment by end user (2015 – 2023) volume in Million units
Table 23: MEA - segment by disease indication (2015 – 2023) value in USD Bn
Table 24: MEA - segment by end user (2015 – 2023) value in USD Bn
Table 25: MEA - segment by disease indication (2015 – 2023) volume in Million units
Table 26: MEA - segment by end user (2015 – 2023) volume in Million units
Table 27: Population aged 80 years or over for the world, regions and income groups, 2000, 2015, 2030 And 2050
Table 28: Percentage of the population of older age group (aged 65 and above) by country: 1950, 1980, 2015, and 2050 (Est.)
Table 28(Contd.): Percentage of the population of older age group (aged 65 and above) by country: 1950, 1980, 2015, and 2050 (Est.)

COMPANIES COVERED
o GlaxoSmithKline
o Pfizer Inc.
o Merck & Co.
o Novartis
o Sanofi Pasteur
o CSL Limited
o Bharat Biotech International
o Biological E Limited
o Serum Institute of India

 

 

ABOUT NPCS

 

NIIR PROJECT CONSULTANCY SERVICES (NPCS) is a reliable name in the industrial world for offering integrated technical consultancy services. NPCS is manned by engineers, planners, specialists, financial experts, economic analysts and design specialists with extensive experience in the related industries.

Our various services are: Detailed Project Report,  Business Plan for Manufacturing Plant, Start-up Ideas, Business Ideas for Entrepreneurs, Start up Business Opportunities, entrepreneurship projects, Successful Business Plan, Industry Trends, Market Research, Manufacturing Process, Machinery, Raw Materials, project report, Cost and Revenue, Pre-feasibility study for Profitable Manufacturing Business, Project Identification, Project Feasibility and Market Study, Identification of Profitable Industrial Project Opportunities, Business Opportunities, Investment Opportunities for Most Profitable Business in India, Manufacturing Business Ideas, Preparation of Project Profile, Pre-Investment and Pre-Feasibility Study, Market Research Study, Preparation of Techno-Economic Feasibility Report, Identification and Section of Plant, Process, Equipment, General Guidance, Startup Help, Technical and Commercial Counseling for setting up new industrial project and Most Profitable Small Scale Business.

NPCS also publishes varies process technology, technical, reference, self employment and startup books, directory, business and industry database, bankable detailed project report, market research report on various industries, small scale industry and profit making business. Besides being used by manufacturers, industrialists and entrepreneurs, our publications are also used by professionals including project engineers, information services bureau, consultants and project consultancy firms as one of the input in their research.

Our Detailed Project report aims at providing all the critical data required by any entrepreneur vying to venture into Project. While expanding a current business or while venturing into new business, entrepreneurs are often faced with the dilemma of zeroing in on a suitable product/line.

 


And before diversifying/venturing into any product, wish to study the following aspects of the identified product:


• Good Present/Future Demand
• Export-Import Market Potential
• Raw Material & Manpower Availability
• Project Costs and Payback Period


We at NPCS, through our reliable expertise in the project consultancy and market research field, Provides exhaustive information about the project, which satisfies all the above mentioned requirements and has high growth potential in the markets. And through our report we aim to help you make sound and informed business decision.

 

The report contains all the data which will help an entrepreneur find answers to questions like:

• Why I should invest in this project?
• What will drive the growth of the product?
• What are the costs involved?
• What will be the market potential?


The report first focuses on enhancing the basic knowledge of the entrepreneur about the main product, by elucidating details like product definition, its uses and applications, industry segmentation as well as an overall overview of the industry sector in India. The report then helps an entrepreneur identify the target customer group of its product. It further helps in making sound investment decision by listing and then elaborating on factors that will contribute to the growth of product consumption in India and also talks about the foreign trade of the product along with the list of top importing and top exporting countries. Report includes graphical representation and forecasts of key data discussed in the above mentioned segment. It further explicates the growth potential of the product.

The report includes other market data like key players in the Industry segment along with their contact information and recent developments. It includes crucial information like raw material requirements, list of machinery and manufacturing process for the plant. Core project financials like plant capacity, costs involved in setting up of project, working capital requirements, projected revenue and profit are further listed in the report.


Reasons for buying the report:

• This report helps you to identify a profitable project for investing or diversifying into by throwing light to crucial areas like industry size, demand of the product and reasons for investing in the product.

• This report provides vital information on the product like its definition, characteristics and segmentation.

• This report helps you market and place the product correctly by identifying the target customer group of the product.

• This report helps you understand the viability of the project by disclosing details like raw materials required, manufacturing process, project costs and snapshot of other project financials.

• The report provides forecasts of key parameters which helps to anticipate the industry performance and make sound business decision.

 

Our Approach:


• Our research reports broadly cover Indian markets, present analysis, outlook and forecast.

• The market forecasts are developed on the basis of secondary research and are cross-validated through interactions with the industry players. 

• We use reliable sources of information and databases.  And information from such sources is processed by us and included in the report.

 

Our Market Survey cum Detailed Techno Economic Feasibility Report Contains following information:

 

 

Ø  Introduction

·         Project Introduction

·         Project Objective and Strategy

·         Concise History of the Product

·         Properties

·         BIS (Bureau of Indian Standards) Provision & Specification

·         Uses & Applications

 

Ø  Market Study and Assessment

·         Current Indian Market Scenario

·         Present Market Demand and Supply

·         Estimated Future Market Demand and Forecast

·         Statistics of Import & Export

·         Names & Addresses of Existing Units (Present Players)

·         Market Opportunity

 

Ø  Raw Material

·         List of Raw Materials

·         Properties of Raw Materials

·         Prescribed Quality of Raw Materials

·         List of Suppliers and Manufacturers

 

Ø  Personnel (Manpower) Requirements

·         Requirement of Staff & Labor (Skilled and Unskilled) Managerial, Technical, Office Staff and Marketing Personnel

 

Ø  Plant and Machinery

·         List of Plant & Machinery

·         Miscellaneous Items

·         Appliances & Equipments

·         Laboratory Equipments & Accessories

·         Electrification

·         Electric Load & Water

·         Maintenance Cost

·         Sources of Plant & Machinery (Suppliers and Manufacturers)

 

Ø  Manufacturing Process and Formulations

·         Detailed Process of Manufacture with Formulation

·         Packaging Required

·         Process Flow Sheet Diagram

 

Ø  Infrastructure and Utilities

·         Project Location

·         Requirement of Land Area

·         Rates of the Land

·         Built Up Area

·         Construction Schedule

·         Plant Layout and Requirement of Utilities

 

Project at a Glance

Along with financial details as under:

 

  •     Assumptions for Profitability workings

  •    Plant Economics

  •    Production Schedule

  •    Land & Building

            Factory Land & Building

            Site Development Expenses

  •    Plant & Machinery

             Indigenous Machineries

            Other Machineries (Miscellaneous, Laboratory etc.)

  •    Other Fixed Assets

            Furniture & Fixtures

            Pre-operative and Preliminary Expenses

            Technical Knowhow

            Provision of Contingencies

  •   Working Capital Requirement Per Month

             Raw Material

            Packing Material

            Lab & ETP Chemical Cost

           Consumable Store

  •   Overheads Required Per Month And Per Annum

         Utilities & Overheads (Power, Water and Fuel Expenses etc.)

             Royalty and Other Charges

            Selling and Distribution Expenses

  •    Salary and Wages

  •    Turnover Per Annum

  •   Share Capital

            Equity Capital

            Preference Share Capital

 

  •    Annexure 1:: Cost of Project and Means of Finance

  •    Annexure 2::  Profitability and Net Cash Accruals

                Revenue/Income/Realisation

                Expenses/Cost of Products/Services/Items

                Gross Profit

                Financial Charges     

                Total Cost of Sales

                Net Profit After Taxes

                Net Cash Accruals

  •   Annexure 3 :: Assessment of Working Capital requirements

                Current Assets

                Gross Working. Capital

                Current Liabilities

                Net Working Capital

                Working Note for Calculation of Work-in-process

  •    Annexure 4 :: Sources and Disposition of Funds

  •    Annexure 5 :: Projected Balance Sheets

                ROI (Average of Fixed Assets)

                RONW (Average of Share Capital)

                ROI (Average of Total Assets)

  •    Annexure 6 :: Profitability ratios

                D.S.C.R

                Earnings Per Share (EPS)

               

             Debt Equity Ratio

        Annexure 7   :: Break-Even Analysis

                Variable Cost & Expenses

                Semi-Var./Semi-Fixed Exp.

                Profit Volume Ratio (PVR)

                Fixed Expenses / Cost 

                B.E.P

  •   Annexure 8 to 11:: Sensitivity Analysis-Price/Volume

            Resultant N.P.B.T

            Resultant D.S.C.R

   Resultant PV Ratio

   Resultant DER

  Resultant ROI

          Resultant BEP

  •    Annexure 12 :: Shareholding Pattern and Stake Status

        Equity Capital

        Preference Share Capital

  •   Annexure 13 :: Quantitative Details-Output/Sales/Stocks

        Determined Capacity P.A of Products/Services

        Achievable Efficiency/Yield % of Products/Services/Items 

        Net Usable Load/Capacity of Products/Services/Items   

       Expected Sales/ Revenue/ Income of Products/ Services/ Items   

  •    Annexure 14 :: Product wise domestic Sales Realisation

  •    Annexure 15 :: Total Raw Material Cost

  •    Annexure 16 :: Raw Material Cost per unit

  •    Annexure 17 :: Total Lab & ETP Chemical Cost

  •    Annexure 18  :: Consumables, Store etc.,

  •    Annexure 19  :: Packing Material Cost

  •    Annexure 20  :: Packing Material Cost Per Unit

  •    Annexure 21 :: Employees Expenses

  •    Annexure 22 :: Fuel Expenses

  •    Annexure 23 :: Power/Electricity Expenses

  •    Annexure 24 :: Royalty & Other Charges

  •    Annexure 25 :: Repairs & Maintenance Exp.

  •    Annexure 26 :: Other Mfg. Expenses

  •    Annexure 27 :: Administration Expenses

  •    Annexure 28 :: Selling Expenses

  •    Annexure 29 :: Depreciation Charges – as per Books (Total)

  •   Annexure 30   :: Depreciation Charges – as per Books (P & M)

  •   Annexure 31   :: Depreciation Charges - As per IT Act WDV (Total)

  •   Annexure 32   :: Depreciation Charges - As per IT Act WDV (P & M)

  •   Annexure 33   :: Interest and Repayment - Term Loans

  •   Annexure 34   :: Tax on Profits

  •   Annexure 35   ::Projected Pay-Back Period And IRR